Table 4.
Major causes of death in individual studies wherever ascertainable, during or after extracorporeal membrane oxygenation therapy
| Study | Causes of death | |||||
|---|---|---|---|---|---|---|
| Multiple organ failure | Significant hemorrhage | Noscomial infection/sepsis | Refractory circulatory failure | Refractory respiratory failure | Others | |
| Kutleša, 2014 (Croatia) | 2 | 1 | 1 | 3 | 1 | |
| Pham, 2013 (France) | 22 | 5 | 1 | 6 | 8 | 3 |
| Weber-Carstens, 2013 (Germany) | NA | NA | NA | NA | NA | NA |
| Roncon-Albuquerque, 2012 (Portugal) | 1 | 2 | 1 | 1 | - | - |
| Takeda, 2012 (Japan) | 4 | 3 | - | - | 3 | 2 |
| Schellongowski, 2011 (Austria) | 3 | 4 | - | - | - | - |
| Noah, 2011 (UK) | 5 | 10 | 1 | 1 | 2 | 3 |
| Patroniti, 2011 (Italy) | 10 | 4 | 5 | 1 | - | 8 |
| Forrest, 2011 (Australia) | 2 | 1 | - | - | 3 | - |
| Beutel, 2011 (Germany) | 12 | - | - | - | - | - |
| Holzgraefe, 2010 (Sweden) | - | 1 | - | - | - | - |
| Davies, 2009 (Australia/NZ) | - | 10 | 1 | - | 4 | - |
Significant hemorrhage includes intracranial hemorrhage. All numbers indicated in the columns reflect number of patients who were thought to have died from the cause mentioned. NA: Data not available